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BACKGROUND & AIMS:
Liver sinusoidal endothelial cells (LSECs) make up a large proportion of the nonparenchymal cells in the liver. LSECs are involved in induction of immune tolerance, but little is known about their functions during hepatitis C virus (HCV) infection. METHODS: Primary human LSECs (HLSECs) and immortalized liver endothelial cells (TMNK-1) were exposed to various forms of HCV, including fulllength transmitted/founder virus, sucrose-purified Japanese fulminant hepatitis-1 (JFH-1), a virus encoding a luciferase reporter, and the HCV-specific pathogen-associated molecular pattern molecules. Cells were analyzed by confocal immunofluorescence, immunohistochemical, and polymerase chain reaction assays. RESULTS: HLSECs internalized HCV, independent of cell-cell contacts; HCV RNA was translated but not replicated. 1 HCV-related liver disease is a leading cause of hepatocellular carcinoma and indication for liver transplantation. Although hepatocytes comprise the majority of the total cell population within the liver, the remaining population of nonparenchymal liver cells, including liver sinusoidal endothelial cells (LSECs), Kupffer cells, hepatic stellate cells (HSCs), is diverse and multifunctional. [2] [3] [4] The highly organized liver architecture allows intimate contact between the distinct cell types.
LSECs comprise approximately 50% of nonparenchymal cells in the liver (approximately 10 11 cells in humans) and have been highly conserved during evolution to clear waste molecules entering the circulation. 5 Earlier work in LSECs has largely focused on Toll-like receptor (TLR)-4 and its ligand, lipopolysaccaride (LPS), which is constantly present in the portal venous blood. 6, 7 However, the precise role of LSECs in sensing other TLR ligands, such as viral products, is just beginning to emerge. 6, 8, 9 In addition to the TLR system, retinoic acid inducible gene-I (RIG-I)-like receptors have been identified as cytosolic receptors for intracellular double-stranded RNA sensing. 10 The relative contribution of TLRs and RIG-I-like receptors as viral sensors varies across cell types and viruses. 10 LSECs are unusual in several respects; they do not secrete an organized basement membrane and are perforated by numerous fenestrations, which are transcytoplasmic canals clustered into sieve plates. 11 LSECs are highly efficient scavengers that pinocytose particles <0.2 mm, allowing them to uptake virus-sized particles. 12 The recent demonstration that LSECs and not Kupffer cells clear the bulk of blood-borne human adenovirus underscores their importance during the viremic phase of any natural viral infection. 12 Expression of the C-type lectin liver/lymph node-specific intercellular adhesion molecule 3-grabbing nonintegrin (L-SIGN) on LSECs has been previously shown to mediate capture of HCV particles and transcytosis of the virus across the endothelial barrier, thereby concentrating infectious particles and potentially facilitating their direct contact with hepatocytes. 13, 14 A recent study points to human LSEC (HLSEC) -derived bone morphogenetic protein 4, negatively regulated by hepatocellular vascular endothelial growth factor-A, in promoting hepatocyte permeability, virus particle entry, and HCV replication. 15 The aim of our study was to interrogate whether HLSECs could directly uptake and sense HCV-RNA and define how the innate immune responses might control HCV replication. We found HLSECs express many of the receptors implicated in HCV attachment and entry 16 and HLSEC-to-hepatocyte contact was dispensable for uptake. HCV encoding a Luciferase reporter demonstrated early viral RNA translation. Primary HLSECs and an immortalized cell line (TMNK-1) responded to various forms of HCV-RNA, including founder/ transmitted virus, sucrose-purified Japanese fulminant hepatitis (JFH-1), and the HCV pathogen-associated molecular pattern (PAMP; substrate for RIG-I), by marked up-regulation of type I/III interferons (IFNs). Exogenous addition of type I/III IFNs broadly induced IFN and IFNsimulated genes (ISGs) responses within HLSECs. Of the ISGs, RSAD2 (encoding viperin) was the most robustly induced in HLSECs by IFN stimulation. Stimulation of HLSECs with either type I/III IFNs led to secretion of exosomes that inhibit HCV replication. Collectively, these data support a previously unappreciated role for HLSECs in the innate immune response to this common disease, with potential to impact other liver-tropic infections.
Materials and Methods

Cells
Primary HLSECs were purchased from Sciencell Research Laboratories (Carlsbad, CA). 17 TMNK-1 cells were provided by A. Soto-Gutierrez (University of Pittsburgh, PA) and the hepatoma cell line Huh 7.5.1 was obtained from Francis Chisari (Scripps Research Institute, La Jolla, CA). HLSECs were maintained in endothelial cell medium supplemented with 5% fetal bovine serum, 1% endothelial cell growth supplement, and 1% penicillin/ streptomycin (Sciencell). TMNK-1 cells were maintained in high glucose Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA). Human microvascular endothelial cells were maintained as described previously. 18 Human hepatocellular liver carcinoma cell lines Huh 7.5.1 and HepG2 (ATCC, Manassas, VA) cells were maintained following manufacturer's instructions.
Fluorescence-activated cell sorting analysis of antigen expression, Western blotting, immunofluorescence, preparation, and use of HCV-founder virus and HCV-PAMP, TLR, and IFN stimulation, gene and protein quantitation, viral replication studies, HLSECs sorting and exosomal isolation, viral control assays, and statistical analyses are detailed in the Supplementary Materials.
Results
Human Liver Sinusoidal Endothelial Cells Express Molecules Required for Attachment, Uptake, and Sensing of Hepatitis C Virus
To investigate the expression of receptors in HLSECs, 8 different lots of primary HLSECs were stained for classical endothelial markers ( Figure 1A ). HLSECs were positive for the surface markers CD31, intercellular adhesion molecule 1, DC-SIGN, L-SIGN, and stabilin-1, but negative for the panleukocyte antigen CD45. LYVE-1 (lymphatic vessel endothelial hyaluronan receptor) is constitutively expressed on LSECs and reportedly absent on other hepatic cells and conventional endothelium. 11, 19 Primary HLSECs also expressed receptors implicated in HCV attachment and/or entry (low-density lipoprotein receptor, the tretraspanin CD81, and scavenger receptor type B1; Figure 1B) . We also verified expression of certain pattern recognition receptors in HLSECs ( Figure 1C ). HLSECs express multiple TLRs implicated in innate antiviral immunity (TLR3/TLR7), as well as RIG-I, the expression of which is increased after 8 hours stimulation with pegylated IFN alfa2 (Western blot inset). The immortalized, differentiated adult human liver endothelial cell line TMNK-1 20 was also phenotyped (Supplementary Figure 1) , sharing most features with primary HLSECs.
Hepatitis C Virus Uptake by Human Liver Sinusoidal Endothelial Cells Does Not Require Contact With Hepatocytes and Is Clathrin-Dependent
In order to determine whether HCV is taken up by HLSECs, we utilized the hepatoma cell line Huh 7.5.1 infected with full-length HCV JFH-1, also known as infectious cell culture-derived HCV. 21 After 5 days of infection, primary HLSECs were added to the culture for an additional 24 hours. Confocal microscopy was performed to localize NS5A, involved in the RNA replicative machinery, 16 within HLSECs. Liver endothelial cells were distinguished from hepatocytes by the different morphology of the Factin structure and by the presence of Keratin 18 filaments (Figure 2AÀC ), the latter only expressed in Huh 7.5.1 ( Figure 2C ). With this experimental approach, we observed infected Huh 7.5.1 in direct contact with HLSEC and both Figure 2 . HCV is taken up by HLECs. Primary HLSECs (A), TMNK-1 (B), and Huh7.5.1 cells (C) were plated for 24 hours and stained for Keratin 18 (K18, green) and F-actin (red). Endothelial cells (contrary to hepatocytes) do not express K18 (magnification 40Â). Co-culture experiment with primary HLECs and Huh7.5.1 was performed as described in the Methods. Cells were stained for NS5A (blue), F-actin (red), K18 (green) and 4 0 6-diamidino-2-phenylindole (DAPI). HCV-NS5A is detected in both cell types, confirming that HLSECs can uptake HCV (magnification 40Â) (D). Primary HLSECs were plated for 24 hours with supernatant of JFH-1Àinfected Huh7.5.1. Cells were stained for F-actin (red) and core or NS5A (blue) (magnification 40Â) (E). The vast majority of TMNK-1 cells exposed to cell-free supernatant from JFH-1Àinfected Huh7.5.1 cells demonstrated HCV-NS5A protein (F) (magnification 25Â). Cells were visualized using confocal microscopy as described in the Methods. Bar ¼ 10 mm.
cell types expressed HCV-NS5A protein within the cytoplasm ( Figure 2D ). For the first time, we were able to show HCV-specific protein within HLSECs. To address if the HCV uptake was cell-contact dependent, we cultured primary HLSECs for 24 hours with cell-free supernatant from Huh 7.5.1/JFH-1 cultures. Confocal microscopy ( Figure 2E ) and Western blot analysis (Supplementary Figure 2) demonstrated the presence of HCV proteins within HLECs. Uptake of virus/viral proteins occurs independently of direct hepatocyte contact. The vast majority (>80%) of TMNK-1 demonstrated HCV protein after 24 hours ( Figure 2F ), which was nondetectable in TMNK-1 cultured with non-HCV-infected supernatants (Supplementary Figure 3) . Liver endothelial cells are known to be avid and efficient scavengers able to take up virus-sized particles. 12 To determine if clathrin-dependent endocytosis 22 was involved, primary HLSECs were pretreated for 15 minutes with 30 mM Pitstop2 (inhibitor of clathrin-dependent endocytosis 23 ) or for 1 hour with 80 mM Dynasore hydrate (inhibitor of the GTPase activity of dynamin 24 ). After pretreatment, cells cultured with supernatant of JFH-1-infected Huh 7.5.1 showed significant reduction of NS5A internalization compared with control cells (determined by confocal microscopy), suggesting a clathrin-dependent uptake by primary HLSECs (data not shown). In contrast to the Huh7 hepatocyte model system, addition of cell culture-derived HCV to primary HLSECs or TMNK-1 did not result in increased HCV copy number at 24, 48, or 72 hours (data not shown), indicating that HLSECs do not sustain replication.
Human Liver Sinusoidal Endothelial Cells Are Permissive for Hepatitis C Virus RNA Infection and Translation: Insights From Direct-Acting Antivirals
In order to examine different steps in the viral life cycle within HLSECs, we used several approaches. A cell-culture adapted JFH-1 virus expressing Gaussia princeps luciferase (GLuc) in frame was infected into TMNK-1 cells and the activity of secreted GLuc in culture supernatants 25 was measured at multiple intervals (2, 8, 16 , and 24 hours post infection). GLuc activity was detected within 8 hours of infection, suggesting that TMNK-1 cells are permissive for HCV viral entry and genome translation. After 8 hours of infection, we could only detect background levels of GLuc activity. When sofosbuvir, an inhibitor of the viral NS5B RNAdependent RNA polymerase, was added to the culture (30 mM), 26 we did not observe any difference in the GLuc activity. These data suggest absence of active replication in TMNK-1 cells (Supplementary Figure 4A) . TMNK-1 cells pretreated with the same concentration of sofosbuvir were also cultured with supernatant from Huh 7.5.1/JFH-1 cultures. The presence of direct-acting antivirals in culture did not affect the detection level of HCV-NS5A within TMNK-1 cells by confocal microscopy (Supplementary Figure 4B and C) . Taken together, these data indicate that HLSECs/TMNK-1 cells can be permissive for HCV entry and translation of the viral genome, but do not sustain productive replication.
Intracellular Hepatitis C Virus RNA Induces Type I and Type III Interferons in Human Liver Sinusoidal Endothelial Cells
The fact that input virus was translated but GLuc activity was rapidly reduced to background level suggested the possibility of a robust innate immune response limiting replication with HLSECs. To investigate the responses elicited by intracellular sensing of HCV-viral RNA without potential contaminants from cell culture-derived HCV supernatants, we used 4 different approaches. First, viral RNA (vRNA) of a full-length infectious molecular clone of HCV known to efficiently transmit infection, transmitted founder (T/F) virus identified by single genome sequencing and phylogenetic inference, 27, 28 was added to cultured TMNK-1. The T/F vRNA (genotype 1a) induced significant up-regulation of type I/III IFNs (black bars) that was reduced by chloroquine (white bars), a lysosomotropic agent that prevents endosomal acidification, thus inhibiting TLR signaling ( Figure 3A ). We found that sucrose-purified HCV virus 29 induced significant transcription of multiple IFNs in TMNK-1 cells ( Figure 3B ). These data indicate that HCV-RNA is taken up directly by HLSECs and induces innate immune responses.
Next, we in vitro-transfected full-length JFH-1 into TMNK-1 cells in the absence or presence of a specific TLR7 antagonist, IRS661. 30 JFH-1 induced highly robust IFNB and IFNLs transcription ( Figure 3C ), and TLR7 inhibition decreased but did not totally abrogate their expression ( Figure 3D ), suggesting other antiviral signaling pathways might be involved. Accordingly, we transfected primary HLSECs with the HCV-genome 3 0 nontranslated poly-U/UC tract, previously shown to function as the HCV-PAMP substrate of RIG-I, the cytosolic pattern recognition receptors for HCV. 31, 32 HCV-PAMP induced strong up-regulation of IFNB and IFNL genes ( Figure 4A ) and significantly higher secretion of IFN-b, IFN-l, and IP-10 (CXCL10, marker of HCV infection 33 ) compared with control ( Figure 4B ). To further confirm the contribution of RIG-I to the transcriptional up-regulation of IFNs within HLSECs, we pretreated TMNK-1 cells with Antarctic phosphatases to remove 5 0 -triphosphate groups required for RIG-I signaling. 34, 35 Phosphatase pretreatment significantly decreased PAMP-induced IFN transcription (Supplementary Figure 5) .
To determine specificity of innate immune response profiles, the primary HLSECs were also stimulated with a synthetic TLR3 ligand (poly I:C) or with a TLR4 ligand (LPS). Poly I:C, an analogue of viral double-stranded RNA, induced only modest IFNA1 up-regulation ( Figure 4C ). LPS exclusively induced up-regulation of TNFA and IL6 ( Figure 4D ). From these experiments, we conclude that the robust upregulation of type I/III IFNs observed in HLSECs with HCV transfection is distinct from TLR3 or TLR4 stimulation.
Interferons Induce Robust IFNL3 and InterferonStimulated Genes From Human Liver Sinusoidal Endothelial Cells
IFNs are known to induce the expression of hundreds of antiviral genes, a process termed cell-autonomous Figure 4 . HLSECs sense HCV-RNA and demonstrate differential response to TLR3 and TLR4 ligation. Primary HLSECs were transfected with the HCV-PAMP for 8 hours (normalized to X-region control) 31 (n ¼ 8) (A). Protein secretion was higher in supernatants of HCV-PAMP-transfected primary HLSECs compared with control as assessed by enzyme-linked immunosorbent assay (representing 3 to 7 experiments) (B). Primary HLSECs stimulated with Poly I:C (TLR3) (C) or LPS (TLR4) (D) (normalized to mock) showed different transcriptional profiles (n ¼ 4). Gene up-regulation was assessed by real-time reverse transcription polymerase chain reaction. Bars represent mean plus SEM, Wilcoxon signed-rank test; *P < .05; **P < .01; ****P < .0001. Wilcoxon signed-rank test (C). Full-length JFH-1-RNA was transfected into TMNK-1 cells for 24 hours in the presence of the IRS661 (TLR7-specific antagonist) or the control (IRS-Ctrl) (n ¼ 3). Fold increase of the messenger RNA was normalized to the IRS-Ctrl considered 100%. IFNA1 and IFNA2 were not included because they were not up-regulated by transfected JFH-1. Wilcoxon signed-rank test (D). For every experiment gene up-regulation was assessed by real-time reverse transcription polymerase chain reaction. Bars represent mean þ SEM; *P < .05; **P < .01; ***P < .001; ****P < .0001.
immunity
36 that results in a "feed-forward" self-amplifying loop. 37 Considering the reported antiviral potency of type III IFNs against HCV replication, 33 we investigated the expression at the gene level of IFNL receptor components (IL28RA and IL10RB) in primary HLSECs. The ratio of the receptor components was higher in primary HLSECs relative to the HepG2 cell line (Supplementary Figure 6) .
Given the robust induction of IFNs within HLSECs after HCV-RNA sensing, we tested IFNs downstream effects by treating primary HLSECs with pegylated IFN alfa2 (used in standard antiviral therapy), recombinant IL-28A (IFNL2), IL-28B (IFNL3), or IL-29 (IFNL1). As shown in Figure 5A, Figure 5B and C), in particular, RSAD2.
39-41 At 24 hours, type I IFN maintained broad induction of ISGs and, of the genes examined, only RSAD2 was significantly up-regulated by type III IFNs ( Figure 5D and E). The distinct set of ISGs with different kinetics of induction supports divergent signaling pathways after receptor engagement. 33 To further explore autocrine/ paracrine effects specifically after HCV-RNA sensing, we added supernatants from HCV-PAMP-transfected primary Wilcoxon signed-rank test; *P < .05; **P < .01; ***P < .001.
HLSECs to newly cultured HLSECs; this resulted in induction of IFNB, IFNLs, and ISG messenger RNAs within HLSECs (Supplementary Figure 7) Figure 6B ). Similar transcriptional trends were observed in our primary HLSECs (data not shown).
In order to be effective, most IFN-induced proteins need to be dispatched to the site of pathogen replication. 36 Considering the close proximity of LSECs to hepatocytes, we tested their ability to control infection by co-culturing HCV-infected Huh7.5.1 cells with either TMNK-1 cells or purified CD8
þ T cells transduced with a tyrosinase receptor. TMNK-1 cells induce significant greater antiviral control ( Figure 6C ) and increased transcription of ISGs ( Figure 6D ). As a complementary approach, supernatants from primary HCV-PAMP-transfected HLSECs also induced control of HCV replication (Supplementary Figure 8A) . Next, using mechanical digestion and sort purification, we found that CD31 þ
CD45
À cells from whole livers of HCV-positive patients demonstrated increased ex vivo expression of IFNB and ISGs ( Figure 6E ) compared with healthy donor livers.
Because of the remarkable expression of IFNs by HLSECs in the current study, we sought to elucidate additional mechanisms whereby IFNs might confer replicative control. The addition of supernatants from IFN alfa (washed after 6 hours) or IFNLs-stimulated TMNK-1 cells (washed after 24 hours) to Huh7.5.1 cells markedly inhibited HCV replication after 5 days of infection (Supplementary Figure 8B) . Type I IFN-stimulated liver nonparenchymal cells are known to secrete exosomes containing ISG products with broad antiviral properties. 17 Supernatants derived from IFN alfastimulated TMNK-1 cells treated with the exosomal release inhibitor nSMase2-inhibitor spiroepoxide (5 mM) 17 throughout the duration of culture were harvested, preincubated with the type I IFN-blocking antibody B18R and cultured with JFH-1 infected Huh7.5.1 cells for 5 days. Blocking exosomal release significantly increased HCV replication (Supplementary Figure 8C) within infected hepatocytes. To further elucidate the contribution of exosomes in control of HCV viral replication, we stimulated TMNK-1 cells with IFN alfa or a cocktail of IFNLs, isolated exosomes (Supplementary Figure 8D) , and tested their ability to control HCV replication in Huh 7.5.1 cells. Exosomes derived from type I/III IFNs-treated TMNK-1 cells demonstrated viral control in a dose-dependent manner ( Figure 6F ).
Although the cell line Huh 7.5.1 produces workable titers of culture-derived virus, these cells are defective in RIG-I and do not express TLR3, 42 therefore, lack innate immune signaling of primary human hepatocytes (PHH). 33, 43 We isolated PHH and established a micro-patterned culture as described previously 44 ; PHHs were subjected to supernatants from either resting or IFN-alfa-treated TMNK-1 cells (IFN-a was washed 6 hours after stimulation, and the supernatants collected at 6 and 24 hours). RSAD2 and ISG56 were significantly up-regulated in the PHH (Supplementary Figure 8E) . Collectively, these data indicate HLSECs confer antiviral responses in neighboring hepatocytes that restrict HCV infection.
Discussion
Despite the fact that LSECs are the first cells in contact with blood flow in hepatic sinusoids and account for the largest proportion of nonparenchymal cells in the liver, 45 little is known about how these cells recognize hepatitis C. Given their strategic anatomic location 46 we reasoned that HLSECs could play a central antiviral role. We show that HLSECs express many of the requisite receptors for antiviral recognition, including TLRs and RIG-I, the cytoplasmic sensor of HCV. HLSECs are permissive for HCV entry and viral translation; moreover, intracellular HCV-RNA sensing triggers robust antiviral pathways that regulate HCV infection in hepatocytes. Transmission of highly diverse viruses such as HCV or HIV across mucosal barriers can be inefficient and is most likely mediated by a single founder (T/F) virus 47 ; we found that exogenous addition of an HCVspecific T/F vRNA to cultured HLSECs induced Type I/III IFN responses. Chloroquine, which inhibits endocytic TLR signaling, significantly attenuated T/F vRNA-induced responses within an HLSEC cell line (TMNK-1). Our results point to both TLR7 (endosomal receptor known to recognize single-stranded RNA and signal through MyD88 48 ) and RIG-I pathways 49 as critical to mediating IFN messages after HCV sensing by HLSECs. The fact that HLSECs demonstrate distinct transcriptional responses to HCV-RNA, Poly I:C, and LPS indicate they have evolved the ability to differentiate between different types of TLR and RIG-I-like receptor stimulation.
Although Type I/III IFNs utilize different receptor complexes, they signal through overlapping Janus activating kinase-signal transducer and activator of transcription intracellular pathways and up-regulate the transcription of ISGs required to control viral infection. 50 Stimulation of HLSECs with type I/III IFNs consistently induced transcription of IFNL3, known to have the greatest in vitro antiviral potency against HCV replication among the IFNLs. 33, 38 Type I IFN induces immediate and vigorous transcription of prototypical ISGs within HLSECs. In hepatocytes, IFNLs have been shown to induce prolonged signal transducer and activator of transcription 1 activation and ISG expression compared with type I IFNs, the effects of which peak early and decline rapidly. 38, 51 Our kinetics analyses indicate that type I IFN affects HLSECs by rapidly inducing ISG15, OAS1, and RIGI (DDX58) with a decrease over time, and RSAD2 is further increased at 24 hours. HLSECs exposed to IFNLs demonstrated an ISG expression profile that is relatively delayed and narrow (limited to RSAD2 or Viperin). Viperin has broad-spectrum antiviral effects 52 and is particularly interesting because it can restrict HCV replication by physically associating with the 
On day 4, CD8
þ T (white bar) or TMNK-1 cells (black bar), were added to infected Huh7.5.1 for 24 hours (n ¼ 3). HCV viral copy number (C), and gene up-regulation (D) were assessed as described in the Methods. Results were normalized to CD8 þ T cells/ Huh7.5.1 co-culture considered 100%. Mann-Whitney test, 2-tailed. Liver sinusoidal endothelial cells (CD45
þ ) isolated form HCV-infected individuals significantly up-regulate IFNB, ISG15, and OAS1 compared with healthy controls (n ¼ 3) (E). Exosomes derived from mock or IFN-treated TMNK-1 cells were added to Huh7.5.1 at the time of infection in increasing doses (5, 10, and 25 mg/mL) for 5 days (F). Exosomes from Peg-IFN alfa2-treated TMNK-1 were isolated after 24 hours (n ¼ 1) and 48 hours (n ¼ 1) with pooled data displayed. Exosomes from IFN-l1/2/3-treated TMNK were isolated after 48 hours (n ¼ 3). Results were normalized to Huh7.5.1/mock-treated exosomes culture considered 100%. One-sample t test. Bars represent mean þ SEM; *P < .05; **P < .01; ***P < .001; ****P < .0001.
HCV-NS5A protein. 39 As further corroboration, supernatants from IFN alfa-stimulated HLSECs increased ISGs in PHHs to a greater extent than supernatants from resting HLSECs (Supplementary Figure 8C) , suggesting that HLSECs might "prime" adjacent hepatocytes to combat HCV infection. The strong antiviral effector responses by HLSECs provide a plausible mechanism to limit HCV replication, extending the concept of "viral repulsion" 53 to the liver microenvironment. Accordingly, we found that HLECs pretreated with IFN alfa and then exposed to cell-culture-derived HCV express less HCV-NS5A protein (Supplementary Figure 9) , suggesting that antiviral responses might prevent uptake and sensing of HCV by adjacent HLSECs. In addition, we found that HLSEC-derived supernatants also up-regulated hepatocyte transcription of suppressor of cytokine signaling-1 ( Supplementary Figure 10) , known to bind to the Janus activating kinases and inhibit catalytic activity. This might provide negative regulation of IFNs. 54 Several limitations of our study are worth addressing. We used isolated primary liver endothelial cells described recently, 17 ex vivo-purified LSECs, as well as an immortalized HLSEC line, TMNK-1. 20, 55, 56 Earlier reports indicate that CD31 þ LYVE-1 þ liver endothelial cells lose their fenestrae in culture, 57 but, when transplanted into mice, exhibit fenestrae in vivo, suggesting that in the appropriate liver microenvironment, these cells resemble true LSECs. 45 We considered using vascular endothelial growth factor-A in order to induce fenestrations, 58, 59 but decided against that approach because it could potentially complicate analyses on HCV replication. 15, 60 Taken together, our compelling data lead to conceptual insights and a novel paradigm identifying HLSECs as central to HCV recognition and immunity (Figure 7) . These results raise a number of intriguing questions, for example, how the use of exogenous IFN to treat viral hepatitis could be expected to induce additional, previously unrecognized antiviral mechanisms involving HLSECs. Additional work is warranted to understand why, despite these innate immune responses, HCV is able to establish persistence and fail eradication with IFN-based antiviral therapy.
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Supplementary Materials and Methods
Flow Cytometric Analysis of Antigen Expression
Multiparameter flow cytometry (fluorescence-activated cell sorting) was performed using a BD FACSCanto II instrument (BD Biosciences, San Jose, CA) compensated with single fluorochromes and analyzed using Diva software (BD Biosciences). Primary and immortalized liver endothelial populations were identified by their characteristic forward scatter/side scatter properties. Anti-CD45-fluorescein isothiocyanate (FITC) (clone HI30), anti-CD209-allophycocyanin (APC) (clone DCN46), and anti-TLR9-APC (clone eB72-1665) were purchased from BD Biosciences (San Jose, CA). Anti-CD81-peridinin chlorophyll-eFluor710 (clone 1D6-CD81) and anti-TLR3-phycoerythrin (PE) (clone TLR3.7) were purchased from eBioscience (San Diego, CA). Anti-L-SIGN-PE (clone 120604), anti-intercellular adhesion molecule-FITC (clone BBIG-I1), anti-LYVE-1-APC (clone 537028), anti-LDL-R-APC (clone 472418), and anti-TLR7-peridinin chlorophyll (clone 533707) were obtained from R&D systems (Minneapolis, MN). Anti-CD146-PE (clone P1H12) was purchased from BioLegend (San Diego, CA). Polyclonal sheep antihuman stabilin-1 was detected with anti-sheep FITCconjugated secondary antibody (R&D). Rabbit monoclonal antibody anti-Occludin (EPR8202-N-terminal; Abcam, Cambridge, MA) and polyclonal rabbit anti-human SR-BI (Novus Biologicals, Littleton, CO) were detected with anti--rabbit-Alexa Fluor 488 antibody (Invitrogen, Carlsbad, CA). Fluorochrome-labeled (V450) monoclonal antibody specific for CD31 (clone WM59; eBioscience) was used to identify liver endothelial cells in the CD45-negative population.
One million cells were stained for surface antigen expression at 4 C in the dark for 30 minutes, washed in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) and 0.01% sodium azide (FACS wash). The pellet was resuspended in 100 mL of 2% paraformaldehyde (Sigma-Aldrich) and incubated for 20 minutes at 4 C. For intracellular antigens, 1 mL BD PermBuffer III (BD Bioscience) was added overnight. Cells were then washed and incubated for 30 minutes in the presence of monoclonal antibodies in the dark at 4 C and washed in 2 mL FACS wash. Isotype-matched control antibodies were used to determine background levels of staining.
Low-density lipoprotein uptake was studied culturing TMNK-1 cells with or without human low-density lipoprotein PE-labeled low-density lipoprotein (20 mg/mL, Invitrogen) for 24 hours at 37 C.
Western Blotting
TMNK-1 cells were harvested on ice and washed twice with cold PBS. Cells were then lysed with a modified RIPA buffer (Tris-HCl 50 mM, 1% NP-40, 0.25% Na-deoxycholate, NaCl 150 mM, EDTA 1 mM [pH 7.4]) to which 1Â protease inhibitors (150 mL in 1 mL of RIPA buffer) was added (cOmplete, Roche, Nutley, NJ). After 30 minutes of agitation at 4 C, cell lysates were centrifuged and pellets were discarded. Protein levels were assayed using a bicinchoninic acid assay (Fisher, Waltham, MA) as per manufacturer's instructions. Samples were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis on Mini-protean TGX Any kD gels (Bio-Rad, Hercules, CA) and transferred onto a nitrocellulose membrane using a wet transfer system. Membranes were blocked for 1 hour with 5% milk in Tris-buffered saline and Tween 20 or PBS and Tween 20, washed, and proteins were analyzed by immunoblotting with standard methods using antibodies specific to RIG-I (mouse, clone Alme-1, 1:750, Enzo Lifescience, Farmingdale, NY) and glyceraldehyde-3-phosphate dehydrogenase (chicken polyclonal 1:1000, Abcam). Viperin was detected using a rabbit monoclonal antibody (clone AT131, 1:1000; Enzo Lifescience). Viral HCV core protein was detected using specific primary antibodies: mouse anti Core (clone-H6-29, 1:1000, Cosmo Bio Co., LTD, Tokyo, Japan). Secondary antibodies conjugated to horseradish peroxidase were obtained from Jackson ImmunoResearch (1:10000, West Grove, PA) and immunoreactive bands were detected with the Immuno-Star HRP Substrate kit (Bio-Rad).
Immunofluorescence
Images were acquired on a Zeiss LSM 510 confocal microscope (Zeiss NLO 510 with META; Zeiss PlanApochromat 63/1.4NA oil; Thornwood, NY) equipped with a temperature-controlled incubation chamber (Solent Scientific, Fareham, UK). Imaging settings were defined empirically to maximize the signal-to-noise ratio and to avoid saturation. In comparative imaging, all settings were kept constant between samples. The illumination was provided by 30 mW Argon (488 nm), 5 mW HeNe (633 nm), and 1 mW HeNe (543 nm) lasers. Image processing was performed using Zeiss ZEN 2009 software. Figures were mounted using Adobe Photoshop CS4 (Adobe System).
For the experimental setup, cells were seeded onto 35-mm glass bottom dishes (MatTek Corporation, Ashland, MA). Before staining, cells were fixed in 4% paraformaldehyde in PBS. Cells were then blocked with 10% normal serum, labeled with primary polyclonal antibodies against HCV-core (clone7-50, 1:100, Thermo Fisher Scientific; Waltham, MA), HCV-NS5A (clone 9E10, 1:100, provided by C. Rice, Rockefeller University, NY), and claudin-1 (rabbit polyclonal 1:100, Life Technologies, Grand Island, NY), washed and labeled with the appropriate secondary antibodies that were conjugated to Alexa-Fluor 633 or Alexa-Fluor 488 (Invitrogen). Keratin 18 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA) was used to distinguish hepatocytes from HLSECs in the co-culture experiments. Factin was concurrently stained with Alexa-Phalloidin 546 (Invitrogen). Images were acquired as described here.
To investigate if TMNK-1 cells sustain HCV viral replication, cells were pretreated for 24 hours with the antiviral drug sofosbuvir, which acts as an inhibitor of viral RNA synthesis (Chemscene, Monmouth Junction, NJ). Control cells were treated with 0.3% dimethyl sulfoxide in Dulbecco's modified Eagle medium. The presence of the antiviral drug was maintained throughout the experiment. Cells were cultured and processed as described here.
Gaussia Luciferase Assay
TMNKs were seeded in 12-well plates (2 Â 10 5 cells per well). Six hours after seeding, cells were pretreated with 30 mM sofosbuvir (or dimethyl sulfoxide as control) overnight. The following day, cells were infected with JFH1QL/GLuc2A virus (containing the cell culture-adaptive mutation Q221L in the NS3 helicase) at 4000 focus-forming units per well for 2 hours and washed 5 times. Cell culture supernatant fluids were collected and re-fed at 2, 8, 16, and 24 hours after infection. Secreted GLuc activity was measured as described previously. 1 
Hepatitis C Virus Founder Virus
Full-length genotype 1a HCV founder virus plasmids were linearized using restriction enzymes (New England BioLabs, Ipswich, MA) and transcribed in vitro (Cell Script, Madison, WI). The final RNA product was quantified using a Nanodrop microspectometer (Thermo Fisher Scientific).
TMNK-1 cells were plated in a 24-well plate at a concentration of 0.5 Â 10 6 cells in 1 mL per well and rested for 3 hours. Chloroquine (100 mM), lysosomotropic agent that prevents endosomal acidification, was added for 30 minutes at 37 C (control cells were treated with water). Founder virus RNA (1 mg), or an equivalent volume of Rnase-free water (control), was diluted in PBS and added exogenously onto the cells for 24 hours at 37 C in 5% CO 2 . Cellular RNA was isolated using RNeasy Mini kit (Qiagen, Valencia, CA), quantified using a Nanodrop microspectometer (Thermo Fisher Scientific), and 1 mg RNA was used to transcribe complementary DNA using Quantitect RT kit (Qiagen). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed using SYBR Green primers and master mix from Qiagen and run on a StepOnePlus qPCR machine (Applied Biosystems, San Francisco, CA). Data were analyzed using the DDCT method. All primers used in the qRT-PCR assays were purchased from Qiagen.
Hepatitis C Virus Pathogen-Associated Molecular Pattern Preparation
Plasmids containing pU/UC and X-region were kindly provided by Dr Michael Gale. 18 The plasmids were amplified using PCR (X-region Forward 5 0 -TAATACGACTCACTA TAGGTGGCTCCATCTTAGCCCTA-3 0 ; X-region Reverse 5 0 -ACTTGATCTGCAGAGAGGCCAGTATCA-3 0 ; HCV pU/UC Forward 5 0 -TAATACGACTCACTATAGGCCATCCTGTTTTTTT CCC-3 0 ; HCV pU/UC Reverse 5 0 -AAAGGAAAGAAAAGGA AAAAAAGAGG-3 0 ) with a high-fidelity polymerase (Invitrogen). The PCR products were separated by electrophoresis on a 1.5% agarose gel. The bands of interest were extracted (Gel extraction kit, Qiagen) and transcribed in vitro (Applied Biosystems). The final product was quantified using a Nanodrop microspectometer (Thermo Fisher Scientific).
Hepatitis C Virus Pathogen-Associated Molecular Pattern Stimulation
HLSECs were plated in a 12-well low-adherence plate at a concentration of 1 Â 10 6 cells in 1 mL per well. One microgram pU/UC RNA (PAMP) or X-region RNA (control) was transfected into the cells (co-incubation with Mirus 2250, Madison, WI) for 8 or 24 hours at 37 C in 5% CO 2 . To assess gene fold up-regulation samples, were then processed and analyzed as described for HCV founder virus stimulation. HLSECs were genotyped for IL28B (rs12979860) as described previously. 2 
Enzyme-Linked Immunosorbent Assays
The multiplex ELISA kit IFN-b, IFN-l (for IFNL1, IFNL2, IFNL3), and IP-10 was performed by PBL Interferon Source (Piscataway, NJ). All supernatants were harvested 24 hours after PAMP and X-region stimulation.
Lipopolysaccharide, Poly I:C, Pegylated Interferon Alfa2, and Type III Interferon Stimulation Indicated primary cells were plated in 12 well lowadherence plates (Costar 353043; Fisher) at a concentration of 1 Â 10 6 cells/mL per well. LPS (0.1 mg/mL), Poly I:C (1 mg/mL), pegylated-IFN alfa2 (0.1 mg/mL), type III IFNs (0.1 mg/mL) or media were added and the cells were incubated at 37 C in 5% CO 2 for 8 or 24 hours. To determine gene fold up-regulation, samples were processed and analyzed as described for HCV founder virus stimulation. . The copy number was determined using a standard curve.
Hepatitis C Virus Infection
Microarray and Bioinformatics of Endothelial Cells
TMNK-1 and HMEC-1 cells were cultured for 48 hours and cellular RNA from 3 independent experiments was hybridized to Human Gene 2.0 Arrays (Affymetrix, Santa Clara, CA) using standard Affymetrix protocols and converted to log2 expression values, with RMA background correction adjusting for guanosine (G) and cytosine (C) content and quantile normalization, 3 as implemented by the statistical/visualization package Partek Genomics Suite v6.6 (Partek, St Louis, MO). The normalized expression values used in the statistical and bioinformatics analysis for this article, as well as the original raw visual data used to calculate these values, have been deposited in the publicly accessible database Gene Expression Omnibus (http:// www.ncbi.nlm.nih.gov/geo/) under the accession number. A false discovery rate of <.001 (analysis of variance) was used to identify transcripts different between the HLSEC and human microvascular endothelial cells, yielding 703 out of a total of 19,556 transcripts considered to be present (log2 gene expression >3 in at least one sample) on the Human Gene 2.0 ST array (Affymetrix).
The platform Ingenuity Pathway Analysis (IPA) (Ingenuity, Redwood City, CA) was used to perform the systems analysis on the 100 out of 703 genes/miRNAs with known relevance to viral infection. IPA uses a Fisher's exact test to identify over-represented connected biological units in a defined set of genes, which can include pathways, cellular functions, or known targets of regulatory genes. In some cases, a confidence score, or z score, can be made on the activation state of the pathway or upstream regulator based on the expression pattern of the associated genes. 4 IPA was also used to group these transcripts into genelimited networks (35 genes maximum) based on evidence of direct or indirect relationships between molecules according to the IPA Knowledge Base.
Exosome Isolation
Exosomes were isolated from TMNK-1-conditioned media using ExoQuick-TC (Systems Bioscience, Mountain View, CA) per manufacturer's protocol.
Characterization by flow cytometry was performed on isolated exosomes using CD63-labeled Dynabeads (Life Technologies, Carlsbad, CA) as per manufacturer's instructions. Bead-bound exosomes were then labeled with anti-CD63-PE (clone H5C6; BD Biosciences) and anti-CD81-peridinin chlorophyll-eFluor 710 (clone 1D6, eBioscience) and quantified with FACSCanto using FACSDiva software.
For exosome viral control assays, exosomes were resuspended in sterile PBS. Total protein content of exosome suspension was determined using BCA Protein Assay (Fisher) and samples were normalized to 200 mg/mL concentration in PBS and stored until use.
Spiroepoxide Assay
Exosome release was blocked using nSMase2-inhibitor spiroepoxide (5 mM) (Santa Cruz Biotechnology) as described previously. 5 Cells were pretreated with spiroepoxide or vehicle (dimethyl sulfoxide) for 30 minutes, washed, and then cultured with spiroepoxide (or vehicle) and stimulated with pegylated interferon alfa2 (100 ng/mL) for 48 hours. Cell-free supernatants were harvested and incubated at room temperature for 1 hour with type I IFN blocking antibody B18R (eBioscience) at a concentration (10 mg/mL) adequate to neutralize exogenous pegylated interferon alfa2. Supernatants were then added to JFH-1-infected hepatocytes at 1:1 ratio with Huh 7.5.1 media and cultured for 5 days. JFH-1 titers were calculated as previously described.
Micropatterned Co-Culture Establishment
Cryopreserved human hepatocytes (Triangle Research Labs, Research Triangle Park, NC) were thawed and diluted with 50 mL warm hepatocyte culture medium. Cell viability was assessed using Trypan blue exclusion. Liverderived nonparenchymal cells, as judged by their size (approximately 10 mm in diameter) and morphology (nonpolygonal), were consistently found to be <1% in these preparations. To create micropatterned co-cultures in 24-well plates, we first produced a hepatocyte pattern by seeding hepatocytes in serum-free hepatocyte culture medium on collagen-patterned substrates 6 that mediate selective cell adhesion. The cells were washed with medium 4-6 hours later, leaving approximately 25,000 attached hepatocytes on 85 collagen-coated islands of 500-mm diameter and 1200-mm center-to-center spacing within each well of a 24-well plate. The patterned hepatocytes were then incubated in serum-supplemented hepatocyte culture medium overnight to promote spreading and complete island coverage. Stromal 3T3-J2 murine embryonic fibroblasts were seeded the next day onto hepatocyte cultures to create micropatterned co-cultures. Culture medium was replaced every 2 days (approximately 300 mL/well) for 7-12 days before incubation with endothelial conditioned supernatants or control medium for 6-24 hours. After the incubation period, cells were washed twice with 1Â PBS, lysed using the RLT buffer (Qiagen), and lysates were kept frozen at À80 C until further processing.
Cells Isolation
Nonparenchymal cells were isolated from explanted liver tissue at the time of liver transplantation for HCVrelated liver disease. Tissue samples were dissected into 1-mm 3 pieces, added to cRPMI 1640 medium and 0.05% collagenase type IV (312 U/mg), and the mixture incubated at 37 C for 60 minutes. The supernatant was removed, diluted in cRPMI 1640 medium, and centrifuged at 125g for 10 minutes. Nonparenchymal cells from healthy donor livers were purchased from Triangle Research Labs (Research Triangle Park, NC).
Purification of the CD31-positive population from nonparenchymal fractions was performed according to manufacturer's protocol (CD31 MicroBead Kit, Miltenyi, San Diego, CA). CD31 þ cells were then stained with antibodies directed to CD31 (eFluorV50, clone WM59; eBioscience) and CD45 (FITC, HI30, BD Biosciences) to identify and sort the CD45
Statistical Analysis
Results are expressed as mean (±SEM). The Wilcoxon signed-rank test was used to compare fold increases of stimulated conditions with control conditions, and the nonparametric Mann-Whitney U test and One-sample t test were used to compare differences between groups. Calculations were performed using Graphpad Prism software. Statistical significance was defined as P < .05. 
